TI
RPRX icon

Trexquant Investment’s Royalty Pharma RPRX Stock Holding History

Trexquant Investment’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,559
Closed -$1.71M – 1864
2025
Q2 		$1.71M Buy
+47,559
New +$1.58M 0.02% 934
2025
Q1 		– Sell
-520,043
Closed -$13.3M – 1834
2024
Q4 		$13.3M Buy
520,043
+430,697
+482% +$11.4M 0.15% 191
2024
Q3 		$2.53M Buy
89,346
+63,487
+246% +$1.76M 0.03% 721
2024
Q2 		$682K Sell
25,859
-147,528
-85% -$4.09M 0.01% 1139
2024
Q1 		$5.27M Sell
173,387
-259,202
-60% -$7.64M 0.11% 282
2023
Q4 		$12.2M Buy
432,589
+117,934
+37% +$3.24M 0.27% 75
2023
Q3 		$8.54M Sell
314,655
-143,633
-31% -$4.27M 0.21% 110
2023
Q2 		$14.1M Buy
458,288
+430,429
+1,545% +$14.6M 0.37% 46
2023
Q1 		$1M Sell
27,859
-19,033
-41% -$706K 0.03% 729
2022
Q4 		$1.85M Buy
+46,892
New +$1.96M 0.05% 429
2022
Q2 		– Sell
-213,440
Closed -$8.32M – 1819
2022
Q1 		$8.32M Buy
213,440
+195,345
+1,080% +$7.67M 0.39% 46
2021
Q4 		$721K Buy
+18,095
New +$703K 0.04% 497
2021
Q3 		– Sell
-9,223
Closed -$378K – 1433
2021
Q2 		$378K Sell
9,223
-22,544
-71% -$959K 0.03% 610
2021
Q1 		$1.39M Buy
+31,767
New +$1.51M 0.13% 209

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's RPRX Position: Q3 2025 in Review

Trexquant Investment sold out of Royalty Pharma (RPRX) in Q3 2025, closing a stake of 47,559 shares — an estimated $1.71M sold.

Trexquant Investment first reported a position in RPRX in Q1 2021 and held it in 14 quarters. The position peaked at $14.1M in Q2 2023. 487 funds tracked by Wall St. Rank hold RPRX as of Q3 2025.

  • Trexquant Investment reported no remaining Royalty Pharma position as of Q3 2025 after selling out during the quarter.
  • Trexquant Investment sold 47,559 Royalty Pharma shares in Q3 2025, an estimated $1.71M.
  • Trexquant Investment first reported a position in Royalty Pharma in Q1 2021 and held it in 14 quarters.
  • Trexquant Investment's Royalty Pharma position peaked at $14.1M in Q2 2023.
  • 487 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2025.

Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.